Source:http://linkedlifedata.com/resource/pubmed/id/17473302
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
17
|
pubmed:dateCreated |
2007-5-2
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1538-3598
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
2
|
pubmed:volume |
297
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1917-20
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading | |
pubmed:year |
2007
|
pubmed:articleTitle |
FDA responds to institute of medicine drug safety recommendations--in part.
|
pubmed:affiliation |
Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Center for Health Studies, Group Health, Seattle, WA 98101, USA. psaty@u.washington.edu
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|